跳至主要内容
临床试验/CTRI/2023/09/057578
CTRI/2023/09/057578尚未招募2 期

Randomized Controlled Clinical Trial Of Oral Administration Of Eranda Taila In The Management Of Udarvartini Yonivyapada With Special Reference To Primary Dysmenorrhea. - NI

Dr Sneha Sureshrao Hake0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1 Painful Menstruation For Atleast 3 Consecutive Cycle
  • 2 Patient With Regular Menstrual Cycle 21 to 35 days

排除标准

  • 1 Patient Having Secondary Dysmenorrhea Like Fibroid Adenomyosis Endometriosis
  • 2 Severe Anemic Hb less than 7 gm percent
  • 3 Abdominal Pain Associated With Excessive Bleeding Per Vagina
  • 4 Irregular Menstrual Cycle
  • 5 Any Other Abdominal Pain Like Gastritis Colitis
  • 6 Polycystic Ovarian Disease

研究者

发起方
Dr Sneha Sureshrao Hake

相似试验